baber/WOPTO huggingface dataset:
Patent CA-2486132-A1 (CA)
Title: Packaging tray
Inventor: MEYER IAN
IPC: B65D85/34
Filed: 2004-10-27
Abstract: A packaging tray for transport and storage of product includes a tray portion and a plurality of cover portions. The tray portions is formed from a first sheet material and defined by a plurality of removably connected retail portions. Each retail portion includes a plurality of pockets formed therein, each adapted to receive the product. Each retail portion further includes an outer edge defined substantially about a periphery of the retail portion and at least one tab extending from the outer edge. Each at least one tab is removably connected with at least one tab of an adjacent retail portion along the line of weakening. The plurality of cover portions are formed from a second sheet material and each is configured for removably engagement with one of the retail portions.
Patent CA-2486342-A1 (CA)
Inventor: BELMONTE MARTINEZ CARLOS
IPC: C07K5/04
Filed: 2003-05-16
Abstract: L'invention concerne des composés de formule (I) capables de bloquer la réponse à des substances chimiques ou stimulations thermiques ou médiateurs de l'inflammation des nocicepteurs, leur procédé d'obtention et les compositions les contenant ; dans laquelle Ar désigne un groupe phényle substitué avec un ou plusieurs groupes halogène ; R¿1? désigne amine, hydroxyle ou thiol, tous étant substitués ou non avec la formule (II) ou non ou avec des groupes aliphatiques cycliques ; R¿2? désigne H ou groupe alkyle, aryle, aralkyle ou acyle ou la formule (III), R¿3? désigne H ou la formule (IV) ; R¿4? et R¿6? désignent H ou groupe aliphatique ou cyclique ; R¿5? désigne H ou la formule (V), R¿7? désigne H ou groupe aliphatique ou cyclique ; Z désigne amine, hydroxyle ou thiol, tous étant substitués ou non avec des groupes aliphatiques ou cycliques ; W désigne une liaison ou la formule (VI) ; X désigne une liaison ou la formule (VII) ; Y désigne amine, substitué ou non avec la formule (VIII) ou groupe alkyle, aryle, aralkyle ou acyle ; m, q et s peuvent varier entre 1 et 9 et n et p peuvent varier entre 1 et 10.
Patent CA-2488054-A1 (CA)
Inventor: UESUGI TOMOKI
IPC: G02B26/08
Filed: 2003-06-27
Abstract: An optical switch, wherein a first light reflective surface (51) and a second reflective surface (52) are formed on the lower half of a mirror block (50) so as to form an angle of 90~relative to each other, the first light reflective surface (51) and the second reflective surface (52) are formed also on the upper half of the mirror block (50) so as to form an angle of 90~relative to each other, and a third light reflective surface (53) and a fourth light reflective surface (54) are formed between the first light reflective surface (51) and the second reflective surface (52) so as to form an angle of 90~relative to each other, whereby the relation of the connection of an input optical fiber to an output optical fiber can be switched by switching an area for reflecting light to the upper half or the lower half of the mirror block (50).
Patent CA-2492361-A1 (CA)
Inventor: HODGKINSON TERENCE GEOFFREY
IPC: H04L49/111
Filed: 2003-08-06
Abstract: Switch requests within a packet switch are allocated by processing switch request data for each input port to generate request data for each input port-output port pairing; and generating an allocation plan by sorting the request data relating to each of the input/output pairs in terms of their queue length, and for each such pair, considered in the sorted order, allocating as many of the requests in the queue as can be accommodated in the remaining time slots.
Patent CA-2492466-A1 (CA)
Title: An l2 method for a wireless station to locate and associate with a wireless network in communication with a mobile ip agent
Inventor: THUBERT PASCAL
IPC: H04W88/08
Filed: 2003-08-29
Abstract: A wireless station having a wireless network device capable of providing a link-layer interface to a wireless network, a method operating at the link layer (L2) in the wireless station, and a carrier medium carrying computer readable code segments that when executed on a processor in the wireless station implement the method. The method includes, prior to the station being associated with a wireless network, wirelessly receiving L2 frames transmitted from one or more wireless access point of one or more wireless networks that the station can hear. The method further includes gathering information about the received L2 frames, including L2 information and L3 information. The L3 information includes whether an AP is sending an IP packet from a mobility agent, such that the station may associate with a wireless network that is in communication with the mobility agent. The method further includes storing information about the wireless networks that the station can hear in a database. The information stored about each wireless network includes one or more of an identifier of the wireless network, the L3 information in the L2 frame received from the AP of the wireless network, a time stamp of when the L2 frame was received from the AP, and an indication of the signal strength of the L2 frame from the AP.
Patent CA-2492654-A1 (CA)
Inventor: SANBERG PAUL R
IPC: C07K14/47
Filed: 2003-07-16
Abstract: L'invention concerne un proc~d~ de purification d'une prot~ine immunosuppressive (HISP) consistant ~ obtenir un surnageant ~ partir des cellules hNT; ~ exposer le surnageant ~ une ~lectrophor­se sur gel de polyacrylamide de pr~paration afin d'obtenir 20 fragments iso~lectriques, y compris un fragment iso~lectrique actif num~ro 10; ~ placer le fragment iso~lectrique actif sur une colonne Bleu-S~pharose afin de lier l'albumine; et ~ recueillir le fragment libre contenant la HISP concentr~e isol~e. Fait ~galement l'objet de cette invention une m~thode de traitement des inflammations utilisant une quantit~ efficace d'HISP. L'HISP est anionique, pr~sente un poids mol~culaire de 40 ~ 100 kDa, un point iso~lectrique d'environ 4,8 et provient du surnageant de cellules hNT, mais non pas de cellules de carcinome embryonnaire NCCIT, de cellules de glioblastome T98G ou de cellules de leuc~mie monocytique THP-1. L'HISP peut maintenir les lymphocytes T dans un ~tat quiescent G´0?/G´1? sans abaisser leur viabilit~. L'HISP perd son activit~ lorsqu'elle est thermotrait~e, pH2, pH11, ou m~lang~e ~ de la trypsine ou ~ une carboxypeptidase, mais non pas ~ une raminidase. L'HISP peut supprimer la prolif~ration de cellules sanguines mononucl~aires p~riph~riques r~pondeuses contenues dans des cultures mixtes lymphocytaires allog~niques; l'HISP peut supprimer la prolif~ration de lymphocytes T et la production d'IL-2 en r~ponse au phorbol 12-myristate 13-ac~tate (PMA), ~ l'ionomycine et ~ la concanavaline-A. L'HISP ne se lie pas au gel h~parine-s~pharose CL-B; ou ~ la r~sine de liaison de l'albumine Bleu-S~pharose. L'HISP est concentr~e par ultrafiltration YM10. L'HISP n'agit pas ~ travers le complexe du r~cepteur CD3 des lymphocytes T ou via des cellules ~ signaux accessoires alt~r~es. L'invention concerne en outre une m~thode de traitement d'inflammations consistant ~ administrer une quantit~ efficace de cellules neuronales hNT.
Patent CA-2496747-A1 (CA)
Inventor: OLIVER MITCHELL B
IPC: H04M1/72406
Filed: 2003-08-28
Abstract: A system and method for displaying an interactive screen, such as an end-user license agreement or verification form, on the graphic display of a wireless device when the wireless device connects to a network server on a wireless network and attempts to access or download software applications and data. The user of the wireless device must then affirmatively interact with the interactive screen in order to access or download a software application or data from the network server. The interactive screen can be transmitted from the network server where the wireless device seeks to access or download an application or data, or can be transmitted from a separate server to the wireless device. The records of the wireless device-server interactions can be stored on a network server or other data stores on the wireless network.
Patent CA-2497291-A1 (CA)
Title: A pier
Inventor: FRANCIS COLIN WILLIAM
IPC: E02D27/16
Filed: 2003-09-02
Abstract: A pier (10) to be driven into a ground surface includes an auger member (11) having a shaft (12) that is rotated in a first direction to drive the auger member into the ground surface, and a compaction member (16) having a sleeve (17) surrounding a portion of the shaft. The compaction member (16) includes a compaction part (18) attached to and extending laterally outwardly of the sleeve (17). A threaded rod (23) engages the shaft (12) and is rotated to cause the compaction member (16) to move down the shaft (12) and compact the soil around the shaft.
Patent CA-2500291-A1 (CA)
Title: Advertising display apparatus
Inventor: ISMAEL AHMED
IPC: G09F1/00
Filed: 2005-03-10
Abstract: An advertising display apparatus is disclosed. The apparatus comprises a printed material display portion and a presentation portion. The display portion includes a plurality of printed material holders for holding printed materials. The presentation portion includes video means for displaying visual images. In use, the visual images can be viewed by passers-by and the printed material holders are positioned such that passers-by can conveniently peruse the information on the printed materials held by the holders and draw printed materials therefrom as desired.
Patent CA-2502118-A1 (CA)
Inventor: HAYASHI YUJI
IPC: A61K38/00
Filed: 2003-10-10
Abstract: L'invention concerne un dérivé de GLP-1 comprenant un peptide présentant une séquence d'acides aminés dérivée à partir d'une séquence d'acides aminés de GLP-1 (7-35) par délétion, substitution et/ou ajout d'un ou de plusieurs acides aminés et présentant une activité GLP-1. Sur le C-terminus de ce dérivé est ajoutée une séquence Waa-(Xaa)n-Yaa (Waa désigne Arg ou Lys ; Xaa représente Arg ou Lys ; n désigne un nombre entier compris entre 0 et 14 ; et Yaa représente Arg, Arg-NH¿2?, Lys, Lys-NH¿2? ou Hse). Ce dérivé présente une absorbabilité transmucosale élevée. En outre, une tolérance à la dipeptidyle peptidase IV peut être conférée au dérivé par la substitution de la position 8 de la séquence d'acides aminés de GLP-1 par Ser, tandis que la tolérance à la trypsine peut être conférée à ce dérivé par la substitution de la position 26 par Gln et de la position 34 par Asn. L'absorbabilité transmucosale du dérivé de GLP-1 mentionné ci-dessus peut également être élevée par une formulation en une préparation avec l'utilisation d'un émulsifiant de graisse à dispositif de commande de charge présentant une charge de surface commandée pour être sur le niveau négatif.
Patent CA-2503353-A1 (CA)
Title: Appareil et procede de compensation du gain d'un controleur de gain automatique
Inventor: BAE SANG-MIN
IPC: H04J13/00
Filed: 2003-10-24
Abstract: La présente invention concerne un appareil et un procédé de compensation de gain d'un contrôleur de gain automatique (AGC) destiné à stabiliser la puissance de réception de données par paquets émises en discontinu dans un système de communication mobile. Un contrôleur de compensation reçoit une valeur AGC du contrôleur AGC, échantillonne cette valeur AGC par un nombre d'échantillons prédéterminé pendant une durée prédéterminée, et obtient un gain de compensation AGC par comparaison d'une valeur prédéterminée avec la différence entre une valeur AGC échantillonnée et un gain de référence pendant une durée prédéterminée. Un dispositif de compensation compense la valeur AGC avec le gain de compensation AGC, corrigeant ainsi des erreurs générées du fait de la nature du contrôleur AGC.
Patent CA-2503727-A1 (CA)
Title: Anti-diabetic agents
Inventor: POLIVKOVA JANA
IPC: C07D209/42
Filed: 2003-10-27
Abstract: The present invention provides compounds of formula (I), the prodrugs thereof, and the pharmaceutically acceptable salts of the compounds and prodrugs, wherein R', R'', R''', and Z are as defined herein; pharmaceutical compositions thereof; and uses thereof in treating diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis, and tissue ischemia.
Patent CA-2505570-A1 (CA)
Title: A child harness
Inventor: BERGKVIST HAKAN
IPC: A47D13/08
Filed: 2003-11-13
Abstract: A child harness that includes two strap loops (10) which pass around respective shoulders of the wearer and which are mutually connected by means of a fastener means (11) on the rear side of the harness. The harness also includes a child carrying pouch on the front side of the harness, so as to be supported on the chest side of the wearer. The fastener means (11) is designed to slide readily along strap loops such as to take along the straps a position that is controlled by the magnitude and the direction of the forces applied via the strap portions that connect with the fastener means (11). The harness also includes a waist belt which connects with the fastener means (11) on the rear side of the harness such as to limit the distance of said fastener means from the waist belt. The back piece is generally triangular in shape, with the top of the triangle connected to the fastener means (11), said back piece functioning to transfer load to the lower part of the wearer~s back.
Patent CA-2507022-A1 (CA)
Inventor: MOGCK GERHARD
IPC: B62D65/00
Filed: 2003-12-02
Abstract: The invention relates to a device for assembling, tuning, and testing motor vehicles. Automobile factories are provided with assembly lines, along which components are delivered to an automobile that is to be produced, are assembled, and further processed by humans or robots as required. The automobiles that are to be produced are continuously moved on wheels at the end of the assembly lines by means of chain-driven, rope-driven, or belt- driven apron conveyors. The aim of the invention is to create a device for assembling motor vehicles, which can be mounted anywhere in a flat hall without modifying the ceiling or floor and can be transported. Said aim is achieved by the fact that the inventive device can be assembled from individual transportable, modular, interconnectable components which can be mounted on a flat surface without using pits or creating floor load. Said device encompasses the conveying mechanisms and assembly units for the motor vehicles that are to be assembled. Disclosed are an embodiment with suspende d conveyors for the motor vehicles and different vehicle test stands that touc h the wheels.
Patent CA-2507868-A1 (CA)
Inventor: COOPER BRET
IPC: C12N15/82
Filed: 2003-12-23
Abstract: Protéines, et acides nucléiques codant ces protéines, impliquées dans la réponse au stress (à la fois biotique et abiotique) chez les plantes, ou associées à ladite réponse. Des utilisations de ces protéines sont également décrites.
Patent CA-2509379-A1 (CA)
Title: Ancrage pour murs creux
Inventor: CROSSLEY WILLIAM A
IPC: F16B13/06
Filed: 2003-12-11
Abstract: Cette invention concerne un ancrage (910) pour montage dans un mur creux (W) fait d'un matériau friable, comprenant une extrémité proximale à collerette (918) dans laquelle vient s'engager un outil rotatif (B) qui fait tourner ledit ancrage (910) sur son axe longitudinal (A) et le fait progressivement pénétrer dans le mur (W). L'ancrage (910) comprend également une extrémité distale (912) faite pour percer le mur (W) au fur et à mesure que ledit ancrage (910) tourne, et une tige (920) comprise entre les extrémités proximale et distale (918, 912). La tige comprend au moins un manchon (924) en position d'escamotage pendant la rotation de l'ancrage (910) dans le mur (W), qui est disposé distalement au delà d'une surface non visible du mur (W) une fois l'ancrage (910) mis en place dans le mur dans une première position. L'ancrage (910) présente un filetage (922) qui prend solidement dans le mur (W). Une fixation filetée (B), telle qu'une vis, est conçue pour être insérée dans l'ancrage (910) et se visser distalement dans le manchon (924) de telle sorte qu'une rotation suffisante de la fixation filetée (B) a pour effet de rappeler l'extrémité distale (912) vers l'extrémité proximale (918) et, par là même, de faire se déplacer le manchon (924) latéralement en le dilatant et de l'engager dans la surface non visible du mur (W).
Patent CA-2509867-A1 (CA)
Inventor: VITON NICHOL C
IPC: G06Q10/06
Filed: 2005-06-14
Abstract: Methods and systems are provided for establishing a hierarchical relationship between a parent or master project schedule and sub-project schedules including tasks and phases required for completion of the parent or master project. When changes are made to data contained in a given parent or master project schedule or to a hierarchically related sub-project schedule, an automatic notification is passed to the owners/managers of affected project schedules so that those parties may accept the proposed change, reject the proposed change, or respond to the submitting party with a counter change proposal.
Patent CA-2512534-A1 (CA)
Inventor: LIU JOSHUA C
IPC: B22D11/06
Filed: 2003-12-10
Abstract: The caster roll (10) is used in the manufacture of metal plate, strip, sheet, or foil. The caster roll (10) includes a cylindrical roll core (12) and at least one metal overlay (14) formed on the roll core (12). The at least one metal overlay (14) defines a plurality of cooling passages (34) for conducting a cooling medium through the at least one metal overlay (14) to cool the roll (10) during use. Additional metal overlays (16) may be formed on top of the at least one metal overlay. (14). The cooling passages (34) may also be formed in the roll core (12).
Patent CA-2513077-A1 (CA)
Title: Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases
Inventor: ALKEN RUDOLF-GIESBERT
IPC: A61P25/18
Filed: 2003-12-18
Abstract: The invention relates to the use of L-DOPA, the derivatives or pharmacologically-acceptable salts thereof for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase. The invention further relates to pharmaceutical compositions which contain L-DOPA, the derivatives or pharmacologically-acceptable salts thereof for the prophylaxis of psychotic diseases along with pharmacologically-acceptable auxiliaries and adjuncts and, furthermore, the combination of L-DOPA, the derivatives or pharmacologically-acceptable salts thereof with enzyme inhibitors for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase and the corresponding pharmaceutical compositions for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase.
Patent CA-2515702-A1 (CA)
Inventor: YANG XIAOPING
IPC: G03H1/02
Filed: 2004-02-13
Abstract: A sensor for the detection of an analyte comprising a cis-diol moiety, which comprises a holographic element comprising a medium and a hologram disposed throughout the volume of the medium, wherein an optical characteristic of the element changes as a result of a variation of a physical property occurring throughout the volume of the medium, and wherein the medium is a polymer comprising a group of formula (I): wherein n is 0, 1, 2, 3 or 4; each X (if present) is independently is an atom or group which, viaan electronic effect, promotes formation of a tetrahedral geometry about the boron atom; and Y is a spacer which, when n is 0 or otherwise optionally, is an atom or group which, via an electronic effect, promotes formation of a tetrahedral geometry about the boron atom. Such a sensor may be used for the detection of glucose.
Patent CA-2515710-A1 (CA)
Title: Hoist for construction material
Inventor: LEIBOVITZ EITAN
IPC: B66C1/10
Filed: 2004-01-28
Abstract: A hoist (80) for construction sites, for carrying loads suspended from a crane. The hoist (80) is C-shaped, suspended at its top arm by a cable (90) of a crane. The bottom arm carries a hook (92), typically vertically movable, for lifting and moving loads about in the construction site. Owing to its lateral opening, the hoist can deliver loads into the interior space of floors, using minimal crew and relying mainly on the crane for maneuverability.
Patent CA-2518365-A1 (CA)
Title: Sign-type lighting fixture assembly
Inventor: MAJEWSKI ROMAN
IPC: F21V21/02
Filed: 2005-09-08
Abstract: A lighting fixture assembly for mounting to an electrical box. The assembly includes a lighting fixture having perimetrical wall structure to support a signage and illuminating means to illuminate the signage. The assembly further includes a canopy for attaching the fixture to the box. The canopy includes extending bendable tabs which are insertable into openings of the wall structure for mounting the canopy to the fixture without need for additional securement hardware.
Patent CA-2518436-A1 (CA)
Title: Method and machine for binding elongate objects together
Inventor: HOYAUKIN PETER
IPC: E04G21/12
Filed: 2004-03-17
Abstract: Machine for binding elongate objects together by means of at least one wire, in particular for lashing reinforcing bars, electric cables or the like. The machine comprises two claws (6, 7) which can be guided down over the objects (8) to be bound together. Means (20) are arranged for feeding the wire (12) along a guide surface (10) of one claw (6) and across to a guide surface (11) of the other claw (7), so that it is shaped into a wire loop surrounding the objects on three sides, the legs of which loop can be twisted together on the fourth side of the objects (8). The twisting-together means comprise an arrangement (14), which is rotatable relative to the claws (6, 7), and which guide the wire (12) when it is fed to and from the claws. The twisting-together arrangement allows the wire length necessary for twisting-together of the legs of the wire loop to be drawn out while a resistance is overcome.
Patent CA-2518533-A1 (CA)
Inventor: IWICKI MARK THOMAS
IPC: A61K47/46
Filed: 2004-03-30
Abstract: This invention relates to an oral suspension of tegaserod or pharmaceutically acceptable salts thereof. In particular, it relates to an oral suspension comprising a power comprising an effective amount otegaserod or a pharmaceutically acceptable salt thereof in a beverage, e.g. apple juice.
Patent CA-2523049-A1 (CA)
Inventor: VOSIKA MATTHEW
IPC: B29C48/32
Filed: 2004-03-08
Abstract: A process for forming a cover for an industrial roll includes the steps of:  providing an elongate cylindrical core (20) having a longitudinal axis (A1);  rotating the core (20) about the longitudinal axis (A1); providing a nozzle (22) movable along a nozzle path (N) that is substantially parallel to and above the core longitudinal axis, the nozzle (22) having at least an upstream outlet (24) and a downstream outlet (26), the nozzle outlets being longitudinally offset a distance (d) from each other; and applying multiple strips of polymeric material to the core through the nozzle outlets as the nozzle moves along the nozzle path such that the downstream strip (28) forms an overlapping spiral inner layer and the upstream strip (36) forms an overlapping spiral outer layer that overlies the inner layer, the inner and outer layers being adhered with the core (20).
Patent CA-2524422-A1 (CA)
Inventor: SANT VINAYAK
IPC: A61K47/38
Filed: 2005-10-25
Abstract: A gastric retention drug delivery system (i.e. a controlled release drug dosage form) formulated so as to promote retention of the dosage form in the upper gastrointestinal tract and in particular the stomach.